Dupont Capital Management Corp Concert Pharmaceuticals, Inc. Transaction History

Dupont Capital Management Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$3.77 - $5.24 $146,483 - $203,600	-38,855 Closed	0 $0
Q1 2021 Apr 29, 2021	BUY	$4.86 - $13.07 $70,965 - $190,848	14,602 Added 60.21%	38,855 $194,000
Q4 2020 Jan 28, 2021	BUY	$9.48 - $12.84 $99,416 - $134,653	10,487 Added 76.18%	24,253 $307,000
Q3 2020 Oct 29, 2020	SELL	$8.67 - $10.82 $145,300 - $181,332	-16,759 Reduced 54.9%	13,766 $135,000
Q2 2020 Jul 24, 2020	BUY	$7.8 - $11.52 $238,095 - $351,648	30,525 New	30,525 $304,000
Q2 2018 Jul 30, 2018	SELL	$16.83 - $21.66 $631,024 - $812,120	-37,494 Closed	0 $0
Q4 2017 Jan 31, 2018	BUY	$13.96 - $29.05 $523,416 - $1.09 Million	37,494	37,494 $970,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.